The Carlyle Group acquired Abingworth LLP for $186.2M base + up to $130M earnout, a transaction completed in August 2022, structured as Acquisition of 100% of the firm; cash plus stock plus performance earnout.
Abingworth LLP operates in Global Private Equity — Healthcare / life sciences, is based in London, United Kingdom. Carlyle acquired Abingworth, a London-based life-sciences investment firm managing nearly $2 billion in assets, to expand its global healthcare investment platform. The deal gave Carlyle rights to 15% of performance allocations on Abingworth's two most recent active funds. The acquisition closed August 1, 2022.
Expand Carlyle's healthcare franchise with dedicated life-sciences investment expertise and add roughly $2 billion of AUM.
Advisory firms were not disclosed for this transaction.